Project Details


The objective of this study is to assess if the symptom, functional capacity and morbidity of patients with NYHA Functional Class III-IV Heart Failure who have been treated for at least three months with ACE inhibition, loop diuretics and cardiac glycosides are affected by addition of an AII receptor antagonist to their medical regime.
Effective start/end date1/10/9630/09/98


  • National Center for Research Resources


Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.